Antibiotic Prescribing Trends in U.S. Hospitals Raise Flags

Efforts needed to curb the use of broad-spectrum drugs, slow the spread of resistance

Antibiotic Prescribing Trends in U.S. Raise Flags
Antibiotic resistance

© iStock

Approximately half of patients admitted to hospitals will receive antibiotics. National antibiotic use patterns illustrate the potential for individual hospitals to curb prescribing of these drugs, an essential step in slowing the spread of resistance and avoiding adverse events. An analysis from the U.S. Centers for Disease Control and Prevention (CDC) has uncovered worrisome trends in hospital prescribing; stewardship efforts should focus on reversing these trends.

A CDC analysis of inpatient antibiotic prescribing data from the Truven Health Analytics’ MarketScan Hospital Drug Database concluded that between 2006 and 2012, overall antibiotic use remained static. (See Figure 1.) However, the prescribing of certain classes of antibiotics changed as follows:

  • Use of broad-spectrum antibiotics increased significantly. Broad-spectrum antibiotics are agents that target a wide array of bacterial pathogens. They include glycopeptides, beta-lactams and beta-lactamase inhibitor combinations, carbapenems, macrolides, and third- and fourth-generation cephalosporins.
  • Use of narrow-spectrum antibiotics decreased. Narrow-spectrum antibiotics are medications effective in treating a limited and targeted group of pathogens. They include penicillins, aminoglycosides, and first- and second-generation cephalosporins.

Antibiotic resistance

Although these estimates measure only the volume, and not the appropriateness, of prescribing, the trend toward using broad-spectrum agents is cause for concern, because these types of antibiotics have been shown to significantly increase the risk of drug-resistant infections.1

Another worrisome trend is that fluoroquinolones were the most commonly prescribed class of antibiotics in hospitals, accounting for more than 16 percent of all antibiotic use. These broad-spectrum antibiotics have significant toxicities that have been associated with serious and sometimes permanent side effects affecting tendons, muscles, joints, nerves, and the central nervous system. Because of these toxicities, the Food and Drug Administration recently issued an advisory recommending that fluoroquinolone use be avoided for patients with uncomplicated bacterial infections, such as urinary tract infections and sinusitis, and that these patients be given alternative treatment options.2 Reducing unnecessary or inappropriate use of fluoroquinolones will help minimize the risks associated with them.

New information on prescribing patterns can support hospital antibiotic stewardship programs, which are designed to optimize antibiotic use, by identifying areas to target stewardship interventions to reduce any inappropriate use.3 Further research is necessary to evaluate the appropriateness of how these drugs are used in U.S. hospitals, but the high volume of fluoroquinolone use and the increasing use of other broad-spectrum antibiotics present potential targets for antibiotic stewardship efforts.

Endnotes

  1. Public Health England, “Management of Infection Guidance for Primary Care for Consultation and Local Adaptation” (May 2016), accessed Nov. 16, 2016, https://www.gov.uk/government/uploads/system/uploads/attachment_data/ file/524984/ Management_of_infection_guidance_for_ primary_care_for_consultation_and_local_adaptation.pdf; Matthew E. Falagas and Petros Kopterides, “Risk Factors for the Isolation of Multi-Drug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa: A Systematic Review of the Literature,” The Journal of Hospital Infection 64, no. 1 (2006): 7–15, doi:10.1016/j.jhin.2006.04.015; Balazs Ivady et al., “Factors Influencing Antimicrobial Resistance and Outcome of Gram-Negative Bloodstream Infections in Children,” Infection 44 no. 3 (2016): 309–321, doi:10.1007/s15010-015-0857-8; and G. Gopal Rao, “Risk Factors for the Spread of Antibiotic-Resistant Bacteria,” Drugs 55, no. 3 (1998): 323–330, doi:10.2165/00003495-199855030-00001.
  2. Food and Drug Administration, “FDA Drug Safety Communication: FDA Updates Warnings for Oral and Injectable Fluoroquinolone Antibiotics Due to Disabling Side Effects,” accessed Sept. 15, 2016, http://www.fda.gov/Drugs/DrugSafety/ucm511530.htm; Food and Drug Administration, “FDA Drug Safety Communication: FDA Advises Restricting Fluoroquinolone Antibiotic Use for Certain Uncomplicated Infections; Warns About Disabling Side Effects That Can Occur Together,” accessed Sept. 15, 2016, http://www.fda.gov/Drugs/DrugSafety/ucm500143.htm.
  3. The Pew Charitable Trusts, “Antibiotic Stewardship Programs Vary in U.S. Hospitals,” 2016, http://www.pewtrusts.org/en/research-and-analysis/fact-sheets/2016/10/antibiotic-stewardship-programs-vary-in-us-hospitals.
The front facade of the Supreme Court of the United States in Washington, DC.
ian-hutchinson-U8WfiRpsQ7Y-unsplash.jpg_master

Agenda for America

A collection of resources to help federal, state, and local decision-makers set an achievable agenda for all Americans

Quick View

Data-driven policymaking is not just a tool for finding new solutions for emerging challenges, it makes government more effective and better able to serve the public interest. In the coming months, President Joe Biden and the 117th Congress will tackle a number of environmental, health, public safety, and fiscal and economic issues—nearly all of them complicated by the COVID-19 pandemic. To help solve specific, systemic problems in a nonpartisan fashion, Pew has compiled a series of briefings and recommendations based on our research, technical assistance, and advocacy work across America.

Lightbulbs
Lightbulbs

States of Innovation

Data-driven state policy innovations across America

Quick View

Data-driven policymaking is not just a tool for finding new solutions for difficult challenges. When states serve their traditional role as laboratories of innovation, they increase the American people’s confidence that the government they choose—no matter the size—can be effective, responsive, and in the public interest.

Antibiotics and Innovation
Antibiotics and Innovation
Project

Antibiotic Use in Human Health Care

Quick View
Project

Antibiotics are among the most frequently prescribed drugs in the United States. The Centers for Disease Control and Prevention estimates that as much as 50 percent of the prescriptions—originating in hospitals and outpatient settings, such as primary care clinics—are unnecessary or inappropriately prescribed.